Gut Microbiota Dysbiosis: A Conceptual and Quantitative Framework Integrating Ecological Causation, Diagnostic Indicators, Population Dynamics Modeling, and a Multistage Therapeutic Protocol

The human gut microbiota is a dense and metabolically active ecosystem that supports digestion, immune calibration, and metabolic homeostasis. Dysbiosis – a compositional and functional shift from a commensal-dominated to a pathobiont-dominated state – is implicated in inflammatory, metabolic, and systemic disease. This conceptual manuscript synthesizes the principal causes of dysbiosis (dietary, pharmacological, host-genetic, and ecological), and consolidates the diagnostic indicators associated with a eubiotic state, including short-chain fatty acid (SCFA) concentrations and alpha-diversity metrics. We highlight two underappreciated mechanisms: metabolic redundancy that masks incipient dysbiosis until a critical threshold is crossed, and early-life microbial disruption that confers durable susceptibility via host-microbiome epigenetic imprinting.A quantitative framework based on the generalized Lotka-Volterra (gLV) and compositional Lotka-Volterra (cLV) equations is developed, together with a metabolite-coupled extension linking SCFA dynamics to bacterial growth, a reaction-diffusion-advection extension for spatial heterogeneity, and phage-bacteria predator-prey models for the enteric virome.The framework is evaluated across four illustrative interaction-matrix scenarios spanning literature-informed parameter ranges, with a full three-species Jacobian stability analysis, a one-dimensional bifurcation sweep, multi-parameter Monte Carlo sensitivity analysis, and Bayesian parameter estimation with a stochastic extension for phage dynamics. All simulation code is provided in full and was executed to generate every quantitative result reported in this manuscript; no simulated value is asserted without a corresponding, reproducible computation, and explicit falsifiability criteria are specified for the framework's principal claims.A five-phase therapeutic protocol – diagnostic profiling, depurative dietary modulation, probiotic/prebiotic repopulation, sustained equilibration, and longitudinal surveillance – is proposed to restore eubiosis, alongside a scientific risk assessment and a roadmap from experimental validation to regulated manufacturing. This manuscript is intended as a reproducible, falsifiable scaffold for subsequent hypothesis-driven and experimental work in microbiome science.